Verdecchia Paolo, Reboldi Gianpaolo, Angeli Fabio, Avanzini Fausto, de Simone Giovanni, Pede Sergio, Perticone Francesco, Schillaci Giuseppe, Vanuzzo Diego, Maggioni Aldo P
Clinical Research Unit in Preventive Cardiology, Hospital S. Maria della Misericordia, Perugia, Italy.
Am J Hypertens. 2007 Sep;20(9):997-1004. doi: 10.1016/j.amjhyper.2007.04.003.
The interpretation of serial electrocardiographic (ECG) changes in hypertensive subjects is uncertain. We tested the hypothesis that serial changes in repolarization and voltage are independent determinants of outcome.
The Hypertrophy at ECG And its Regression during Treatment (HEART) Survey was a prospective observational study performed at 61 centers. We studied 711 subjects with hypertension and ECG left-ventricular hypertrophy (LVH) at entry. Tracings from 496 subjects at entry and one or more visits during follow-up were available for central reading.
The prevalence of ECG LVH progressively decreased by 49.6% at 3 years. The crude rate of a prespecified primary composite end point of cardiovascular events was 4.17 per 100 subjects per year (95% confidence interval [CI], 3.27 to 5.33). We used Cox regression models of ECG LVH indexes as time-varying covariates at baseline and at follow-up. Time-varying LVH, defined as an absence of ST-T alterations ("strain"), was associated with a lower event rate hazard ratio (HR), 0.47; 95% CI, 0.28 to 0.78; P = .0035), whereas the LVH changes defined in terms of ECG voltages did not achieve significance (HR, 0.91; 95% CI, 0.74 to 1.13; P = .39). The crude event rate in subjects with versus without in-treatment ST-T alterations on the last available ECG before the event or before censoring was 8.38 versus 3.17 per 100 subjects per year (P < .0001).
In this study of subjects with hypertension and ECG LVH at entry, serial changes in repolarization significantly predicted the prognosis, independent of voltage change (which was not significantly predictive in this study). The persistence or new development of ST-T alterations identifies subjects at very high risk of cardiovascular events.
高血压患者系列心电图(ECG)变化的解读尚不确定。我们检验了复极和电压的系列变化是结局的独立决定因素这一假设。
心电图肥大及其治疗期间的消退(HEART)调查是一项在61个中心进行的前瞻性观察性研究。我们研究了711例入组时患有高血压且心电图左心室肥大(LVH)的受试者。有496例受试者入组时及随访期间一次或多次就诊时的心电图可供中心阅片。
3年时心电图LVH的患病率逐渐下降了49.6%。预先设定的心血管事件主要复合终点的粗发生率为每年每100例受试者4.17例(95%置信区间[CI],3.27至5.33)。我们使用心电图LVH指数的Cox回归模型作为基线和随访时的时变协变量。时变LVH定义为无ST-T改变(“劳损”),与较低的事件发生率风险比(HR)相关,为0.47;95%CI,0.28至0.78;P = 0.0035),而根据心电图电压定义的LVH变化未达到显著性(HR,0.91;95%CI,0.74至1.13;P = 0.39)。在事件发生前或 censoring 前最后一次可用心电图上有或无治疗期间ST-T改变的受试者中,粗事件发生率分别为每年每100例受试者8.38例和3.17例(P < 0.0001)。
在这项对入组时患有高血压且心电图LVH的受试者的研究中,复极的系列变化显著预测了预后,独立于电压变化(在本研究中电压变化无显著预测性)。ST-T改变的持续存在或新出现表明受试者发生心血管事件的风险非常高。